New York, New York (PRWEB) September 06, 2012
Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective medical devices, has filed a lawsuit alleging that the DePuy ASR hip implant caused painful complications in a Florida man. The suit was filed on August 24th in the U.S. District Court for the Northern District of Ohio, Western Division (Case No. 1:12-dp-23372) where it is one of many cases pending in the multidistrict litigation as part of the In Re: DePuy Orthopaedics, Inc. ASR Hip Implant Products Liability Litigation (MDL No. 1:10 md 2197). DePuy Orthopaedics, Inc., DePuy Inc., DePuy International Limited, Johnson & Johnson, Johnson & Johnson Services, Inc. and Johnson & Johnson International have been named as Defendants.
According to the Complaint, the Plaintiff received the DePuy ASR hip replacement on both hips, most recently in July 2009. Thereafter, he suffered from bilateral pain and elevated chromium and cobalt levels, allegedly due to the ASR hip implant. The suit claims that he could not have known that these injuries resulted from the device until he learned of the recall, which occurred in August 2010 after data showed that the device was failing in a large number of patients. The lawsuit also asserts that the Plaintiff could not have known that he was being affected by the increased levels of chromium and cobalt until he received the results of his blood work. Among other things, the suit is alleging personal injury, economic loss and loss of services on behalf of the Plaintiff.
The DePuy ASR hip implant and other types of metal-on-metal hip replacements have been associated with a high rate of failure and various complications, allegedly due to metal ions released by the implant when the surfaces rub together. According to a study published in the July Orthopedics journal, 92 percent of revisions occurred relatively early in the post operative period-within three years of implantation. The month prior, a study published in Chemical Communications found evidence of genotoxicity among the ions released by all-metal hips, which suggests that the devices may play a role in damaging a cell’s genetic material.
In June, a U.S. Food and Drug Administration (FDA) advisory panel met to discuss the risks and benefits of metal-on-metal hip implants. Overall, the experts found that there is minimal evidence to support the use of all-metal hips in the future. For patients who already have the implant, panelists advised X-rays, yearly physicals, blood screening and other methods to detect abnormalities. The FDA has asked 21 manufacturers, including Johnson & Johnson, to conduct post market safety studies on metal-on-metal hip implants.
Parker Waichman LLP continues to offer free legal consultations to victims of DePuy ASR and other metal-on-metal hip replacement injuries. If you or a loved one experienced premature failure of your implant or other health problems associated with a recalled DePuy ASR Hip Implant or other metal-on-metal hip replacement device, please contact their office by visiting the firm's DePuy ASR hip implant injury page at yourlawyer.com. Free case evaluations are also available by calling 1 800 LAW INFO (1-800-529-4636).
Parker Waichman LLP
Gary Falkowitz, Managing Attorney